Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 50.0% in July

Cibus, Inc. (NASDAQ:CBUS) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,650,000 shares, an increase of 50.0% from the June 30th total of 1,100,000 shares. Currently, 10.8% of the company’s stock are short sold. Based on an average trading volume of 157,700 shares, the short-interest ratio is currently 10.5 days.

Institutional Investors Weigh In On Cibus

A number of hedge funds and other institutional investors have recently bought and sold shares of CBUS. Citigroup Inc. acquired a new stake in Cibus during the 3rd quarter valued at $199,000. Blue Trust Inc. acquired a new stake in Cibus during the 4th quarter valued at $301,000. Indie Asset Partners LLC increased its holdings in Cibus by 30.1% during the 4th quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock valued at $332,000 after purchasing an additional 3,921 shares in the last quarter. Cerity Partners LLC acquired a new stake in Cibus during the 4th quarter valued at $323,000. Finally, Gladius Capital Management LP acquired a new stake in shares of Cibus in the 4th quarter valued at $56,000. 33.81% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Alliance Global Partners assumed coverage on Cibus in a research note on Monday. They set a “buy” rating and a $25.00 target price for the company. Canaccord Genuity Group restated a “buy” rating and set a $22.00 target price on shares of Cibus in a research note on Friday, July 19th. HC Wainwright restated a “buy” rating and set a $25.00 target price on shares of Cibus in a research note on Friday, May 10th. Finally, Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a research note on Friday, July 19th.

Cibus Stock Up 2.8 %

Shares of CBUS stock traded up $0.28 during mid-day trading on Monday, reaching $10.13. The stock had a trading volume of 51,329 shares, compared to its average volume of 105,081. The firm’s 50 day simple moving average is $10.85 and its 200 day simple moving average is $15.58. Cibus has a one year low of $7.41 and a one year high of $23.18. The firm has a market cap of $218.25 million, a PE ratio of -0.54 and a beta of 1.91.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, May 9th. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($1.01) by ($0.11). The company had revenue of $0.55 million for the quarter, compared to the consensus estimate of $0.40 million. Cibus had a negative return on equity of 23.33% and a negative net margin of 12,313.28%. During the same quarter last year, the business earned ($5.45) EPS. Sell-side analysts forecast that Cibus will post -3.22 earnings per share for the current fiscal year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.